title: Ongoing Clinical Trials.
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D000077341:Lapatinib; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism*; D011799:Quinazolines / Q000008:administration & dosage*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D000077341:Lapatinib; D010446:Peptide Fragments; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases; C561872:HER2 peptide (369-377)